share_log

Altamira Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Altium Capital Management, LP EIN:(9.9%),Altium Growth Fund, LP EIN:(9.9%), etc.

Altamira Therapeutics | SC 13G:超過5%持股股東披露文件-Altium Capital Management, LP EIN:(9.9%),Altium Growth Fund, LP EIN:(9.9%)等

美股sec公告 ·  2019/05/23 17:02
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息